Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Line Abildgaard Ryberg"'
Autor:
Long V. Pham, Alexander P. Underwood, Alekxander Binderup, Ulrik Fahnøe, Carlota Fernandez-Antunez, Blanca Lopez-Mendez, Line Abildgaard Ryberg, Andrea Galli, Christina Sølund, Nina Weis, Santseharay Ramirez, Jens Bukh
Publikováno v:
Emerging Microbes and Infections (2024)
The evolution of SARS-CoV-2 has led to the emergence of numerous variants of concern (VOCs), marked by changes in the viral spike glycoprotein, the primary target for neutralising antibody (nAb) responses. Emerging VOCs, particularly omicron sub-line
Externí odkaz:
https://doaj.org/article/a92a700b014849119526b7299e799525
Autor:
Karen Anbro Gammeltoft, Yuyong Zhou, Line Abildgaard Ryberg, Long V. Pham, Alekxander Binderup, Carlos Rene Duarte Hernandez, Anna Offersgaard, Ulrik Fahnøe, Günther Herbert Johannes Peters, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein
Publikováno v:
Viruses, Vol 15, Iss 9, p 1970 (2023)
Nirmatrelvir, which targets the SARS-CoV-2 main protease (Mpro), is the first-in-line drug for prevention and treatment of severe COVID-19, and additional Mpro inhibitors are in development. However, the risk of resistance development threatens the f
Externí odkaz:
https://doaj.org/article/68742ea5f82c460db78afaf14d9d85da
Autor:
Yuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg, Long V. Pham, Ulrik Fahnøe, Alekxander Binderup, Carlos Rene Duarte Hernandez, Anna Offersgaard, Carlota Fernandez-Antunez, Günther Herbert Johannes Peters, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein
The oral protease inhibitor nirmatrelvir is expected to play a pivotal role for prevention of severe cases of coronavirus disease 2019 (COVID-19). To facilitate monitoring of potentially emerging resistance, we studied severe acute respiratory syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::205d0aa6c9f6984173d452cb9eb2afbb
https://doi.org/10.1101/2022.06.06.494921
https://doi.org/10.1101/2022.06.06.494921
Autor:
Yuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg, Long V. Pham, Helena Damtoft Tjørnelund, Alekxander Binderup, Carlos Rene Duarte Hernandez, Carlota Fernandez-Antunez, Anna Offersgaard, Ulrik Fahnøe, Günther Herbert Johannes Peters, Santseharay Ramirez, Jens Bukh, Judith Margarete Gottwein
Publikováno v:
Zhou, Y, Gammeltoft, K A, Ryberg, L A, Pham, L V, Tjørnelund, H D, Binderup, A, Hernandez, C R D, Fernandez-Antunez, C, Offersgaard, A, Fahnøe, U, Peters, G H J, Ramirez, S, Bukh, J & Gottwein, J M 2022, ' Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system ', Science Advances, vol. 8, no. 51, eadd7197 . https://doi.org/10.1126/sciadv.add7197
The oral protease inhibitor nirmatrelvir is of key importance for prevention of severe coronavirus disease 2019 (COVID-19). To facilitate resistance monitoring, we studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) escape from nirma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d727551774267d20853f0010a21cfc8
https://orbit.dtu.dk/en/publications/3f6c81f6-93ab-4100-b45b-e62a8282a572
https://orbit.dtu.dk/en/publications/3f6c81f6-93ab-4100-b45b-e62a8282a572
Autor:
Jens Bukh, Carlota Fernandez-Antunez, Nina Weis, Andrea Galli, Line Abildgaard Ryberg, Jean Dubuisson, Alexander Underwood, Christina Sølund, Martin Schou Pedersen, Long V. Pham, Santseharay Ramirez, Judith M. Gottwein, Lotte S. Mikkelsen, Sandrine Belouzard, Shan Feng, Ulrik Fahnøe
Publikováno v:
Antimicrobial Agents and Chemotherapy
Efforts to mitigate the coronavirus disease 2019 (COVID-19) pandemic include the screening of existing antiviral molecules that could be repurposed to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Although SARS-CoV-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d38f190592ca838344e00c226ceb332a
https://doi.org/10.1128/aac.00097-21
https://doi.org/10.1128/aac.00097-21